Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
AVALO THERAPEUTICS INC
Ticker: AVTX
CUSIP: 05338F306
Class: COM NEW
PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)
Note: Option positions (PUT/CALL) are excluded.
Q3 2025
Shares
24,628
Value ($000)
$313
Avg Close
$8.60
Range
$4.61 - $14.07
Period
Shares
Value ($000)
Average Close
Price Range
Q3 2025
24,628
$313
$8.60
$4.61 - $14.07